| ABTS | 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) |
| AKT | protein kinase B |
| AUC | area under the curve |
| BACE1 | beta-site amyloid precursor protein cleaving enzyme |
| CAT | catalase |
| α-CD | α-cyclodextrin |
| β-CD | β-cyclodextrin |
| γ-CD | γ-cyclodextrin |
| CDs | cyclodextrins |
| COX-2 | cyclooxygenase 2 |
| CryoTEM | cryogenic transmission electron microscopy |
| DIMEB | heptakis-(2,6-di-O-methyl)-β-cyclodextrin |
| DMPC | dimyristoyl phosphatidylcholine |
| DODA-GLY-PEG2000 | 2-dioctadecylcarbamoyl-methoxyacetylamino) acetic acid (ω-methoxy)-polyethylene glycol 2000 ester |
| DOPC | 1,2-dioleoyl-sn-glycero-3-phosphocholine |
| DSC | Differential Scanning Calorimetry |
| EMA | European Medicines Agency |
| ERK | extracellular signal-regulated kinases |
| FAK | focal adhesion kinase |
| FDA | Food and Drug Administration |
| FGFR1 | fibroblast growth factor receptor |
| FIS-β-CD | fisetin β-cyclodextrin complex |
| FIS-HP-β-CD | fisetin 2-Hydroxypropyl-β-cyclodextrin complex |
| FRAP | ferric reducing antioxidant power assay |
| GSH | reduced glutathione |
| GSK-3 β | glycogen synthase kinase 3 beta |
| GPx | glutathione peroxidase |
| GRAS | generally recognized as safe |
| HaCaT | Cultured Human Keratinocyte |
| HP-β-CD | 2-Hydroxypropyl-β-cyclodextrin |
| HPC | hydroxypropyl cellulose |
| HPMC | hydroxypropyl methylcellulose |
| HSA-NPs | human serum albumin nanoparticles |
| IL-1α | interleukin-1α |
| IL-1β | interleukin-1β |
| IL-6 | interleukin 6 |
| IL-8 | interleukin 8 |
| iNOS | inducible nitric oxide synthase |
| iRhom2 | the inactive rhomboid protein 2 |
| LDL | low-density lipoprotein |
| LL/2 | Lewis lung carcinoma cell line |
| LLC | Lewis lung carcinoma |
| MAPK | mitogen-activated protein kinases |
| MPEG-PCL | methoxy poly(ethylene glycol)-poly(ε-caprolactone) |
| mTOR | serine-threonine protein kinase |
| mTORC2 | mammalian target of rapamycin complex 2 |
| NLRP3 | the nucleotide-binding oligomerization domain (NOD)-like receptor pyrin domain containing 3 |
| NF-κB | nuclear factor kappa-light-chain-enhancer of activated B cells |
| NO | nitric oxide |
| NPs | nanoparticles |
| Nrf2 | nuclear factor erythroid 2-related factor 2 |
| ORAC | oxygen radical absorbance capacity |
| PCL | poly-(ε-caprolactone) |
| PCOS | polycystic ovary syndrome |
| PGE2 | prostaglandin E2 |
| PI3K | phosphoinositide-3-kinase |
| PLA | poly(lactic acid) |
| PLGA | poly(lactic-co-glycolic acid |
| PLGA-PEG-COOH | poly(D,L-lactic-co-glycolic acid)-block-poly(ethylene glycol) carboxylic acid |
| PPAR-γ | the peroxisome proliferators-activated receptors gamma |
| PTEN | phosphatase and tensin homolog deleted on chromosome 10 |
| PVA | polyvinyl alcohol |
| PVP | poly(vinylpyrrolidone) |
| QABCD | quaternary ammonium β-cyclodextrin |
| RAMEB | randomly methylated β-cyclodextrin |
| ROS | reactive oxygen species |
| SBE-β-CD | sulfobutylether β-cyclodextrin |
| SHPβ-CD | succinyl-2-hydroxypropyl β-cyclodextrin |
| SLN | solid lipid nanoparticles |
| SLS | sodium lauryl sulfate |
| SNEDDS | self-nonoemulsifying drug delivery system |
| SOD | superoxide dismutase |
| TLR4 | toll-like receptor 4 |
| TNF-α | tumor necrosis factor-alpha |
| TRAIL | tumor necrosis factor-related apoptosis-inducing ligand |
| VEGF | vascular endothelial growth factor |